Use of statins, amiodarone, direct oral anticoagulants and NSAIDs in chronic liver disease: a guide for general clinicians

Patients with chronic liver disease have associated comorbidities that require treatment, including cardiovascular disease, arrhythmias, cerebrovascular accidents and pain. These medications may affect the liver disease. Due to the complexity of medical problems in patients with chronic liver diseas...

Full description

Bibliographic Details
Main Authors: Sileno Sean, Chirila Razvan M., Harris Dana M.
Format: Article
Language:English
Published: Sciendo 2020-12-01
Series:Romanian Journal of Internal Medicine
Subjects:
Online Access:https://doi.org/10.2478/rjim-2020-0018
id doaj-7b06bbe840f04f7181cffbefed66f29a
record_format Article
spelling doaj-7b06bbe840f04f7181cffbefed66f29a2021-09-05T14:01:27ZengSciendoRomanian Journal of Internal Medicine2501-062X2020-12-0158418118710.2478/rjim-2020-0018rjim-2020-0018Use of statins, amiodarone, direct oral anticoagulants and NSAIDs in chronic liver disease: a guide for general cliniciansSileno Sean0Chirila Razvan M.1Harris Dana M.2Mayo Clinic Department of Internal Medicine, Jacksonville, FloridaMayo Clinic Department of Internal Medicine, Jacksonville, FloridaMayo Clinic Department of Internal Medicine, Jacksonville, FloridaPatients with chronic liver disease have associated comorbidities that require treatment, including cardiovascular disease, arrhythmias, cerebrovascular accidents and pain. These medications may affect the liver disease. Due to the complexity of medical problems in patients with chronic liver disease, treating clinicians benefit from targeted guidance for their care.https://doi.org/10.2478/rjim-2020-0018liver enzymesaminotransferasesbenefitsrisk factorsrecommendations
collection DOAJ
language English
format Article
sources DOAJ
author Sileno Sean
Chirila Razvan M.
Harris Dana M.
spellingShingle Sileno Sean
Chirila Razvan M.
Harris Dana M.
Use of statins, amiodarone, direct oral anticoagulants and NSAIDs in chronic liver disease: a guide for general clinicians
Romanian Journal of Internal Medicine
liver enzymes
aminotransferases
benefits
risk factors
recommendations
author_facet Sileno Sean
Chirila Razvan M.
Harris Dana M.
author_sort Sileno Sean
title Use of statins, amiodarone, direct oral anticoagulants and NSAIDs in chronic liver disease: a guide for general clinicians
title_short Use of statins, amiodarone, direct oral anticoagulants and NSAIDs in chronic liver disease: a guide for general clinicians
title_full Use of statins, amiodarone, direct oral anticoagulants and NSAIDs in chronic liver disease: a guide for general clinicians
title_fullStr Use of statins, amiodarone, direct oral anticoagulants and NSAIDs in chronic liver disease: a guide for general clinicians
title_full_unstemmed Use of statins, amiodarone, direct oral anticoagulants and NSAIDs in chronic liver disease: a guide for general clinicians
title_sort use of statins, amiodarone, direct oral anticoagulants and nsaids in chronic liver disease: a guide for general clinicians
publisher Sciendo
series Romanian Journal of Internal Medicine
issn 2501-062X
publishDate 2020-12-01
description Patients with chronic liver disease have associated comorbidities that require treatment, including cardiovascular disease, arrhythmias, cerebrovascular accidents and pain. These medications may affect the liver disease. Due to the complexity of medical problems in patients with chronic liver disease, treating clinicians benefit from targeted guidance for their care.
topic liver enzymes
aminotransferases
benefits
risk factors
recommendations
url https://doi.org/10.2478/rjim-2020-0018
work_keys_str_mv AT silenosean useofstatinsamiodaronedirectoralanticoagulantsandnsaidsinchronicliverdiseaseaguideforgeneralclinicians
AT chirilarazvanm useofstatinsamiodaronedirectoralanticoagulantsandnsaidsinchronicliverdiseaseaguideforgeneralclinicians
AT harrisdanam useofstatinsamiodaronedirectoralanticoagulantsandnsaidsinchronicliverdiseaseaguideforgeneralclinicians
_version_ 1717810157215285248